Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults.


Journal

The new microbiologica
ISSN: 1121-7138
Titre abrégé: New Microbiol
Pays: Italy
ID NLM: 9516291

Informations de publication

Date de publication:
01 2019
Historique:
received: 08 04 2019
accepted: 08 04 2019
pubmed: 24 1 2019
medline: 13 7 2019
entrez: 24 1 2019
Statut: ppublish

Résumé

To compare mucosal flora in HIV-positive and HIV-negative subjects, to assess chemosusceptibility patterns of carriage isolates and to evaluate possible predisposing factors within the two groups. We analyzed microbes isolated from nasopharyngeal swabs in virologically suppressed and immunologically stable HIV-positive adult outpatients (n=105) at baseline and after 12 months and in an age-matched cohort of HIV-negative outpatients (n=100) at baseline. Bacteria and Candida spp strains were isolated and identified through standard biochemical assays and chemosusceptibility tests were performed. Multi Locus Sequence Typing was also determined to characterize Staphylococcus aureus isolates from HIV-infected persistent carriers. In HIV-positive patients a significantly higher rate of colonization by S. aureus as compared to HIV-negative controls was observed (19% vs 8%, p=0.02), with a relevant percentage of penicillin resistant strains (15% vs 0, p=0.24). Methicillin resistant strains were recovered only from HIV-positive subjects. Overall HIV-positive status was the only predictor of S. aureus colonization (OR 2.77, 95% CI 1.03;7.41, p=0.04). The nasopharyngeal bacterial flora differs between HIV-positive and HIV-negative subjects and appears relevant for possible development of staphylococcal infections in HIV-positive patients.

Identifiants

pubmed: 30671585
pii: 496N059

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-42

Auteurs

Barbara Rossetti (B)

Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena Italy.

Francesca Lombardi (F)

Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.

Simone Belmonti (S)

Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.

Marco Maria D'Andrea (MM)

Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Department of Biology, University of Rome Tor Vergata, Rome, Italy.

Giacinta Tordini (G)

Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Alessandro D'Avino (A)

Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.

Alberto Borghetti (A)

Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.

Davide Moschese (D)

Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy.

Andrea De Luca (A)

Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena Italy.
Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Francesca Montagnani (F)

Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena Italy.
Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH